Dealing with Rare and Orphan Diseases:The Technology Imperative
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Dealing with Rare and Orphan Diseases:The Technology Imperative
-
Narrated by:
-
By:
About this listen
In this episode of Future of Humanity, we will be talking about Rare Diseases with Dr. Vijay Chandru, the Founder and Executive-Chairman of Strand Life Sciences based in Bangalore, India.
The fact is that very few people, mostly children, get these diseases due primarily to random faulty genes. Given that the market size is small, pharmaceutical companies do not always focus on finding a cure; hence they are sometimes called "orphan" diseases. Even when one finds a cure, the cost to the patients and their families could be prohibitive.
Professor Chandru and I will be talking about the different technological interventions that are being pursued across the world to deal with this difficult health issue, and the prognosis for success.
What listeners say about Dealing with Rare and Orphan Diseases:The Technology Imperative
Average Customer RatingsReviews - Please select the tabs below to change the source of reviews.
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.